Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Mendel

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Archives of Internal Medicine|July 25, 2000
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trialF G McMahon, K Fujioka, B N Singh, et al.
Endocrinology|January 1, 1989
Uptake of cortisol by the perfused rat liver: validity of the free hormone hypothesis applied to cortisolC M Mendel, R W Kuhn, R A Weisiger, et al.
JAMA|February 7, 1986
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathyC M Mendel, R F Klein, D A Chappell, et al.
Biochemistry|March 21, 1989
Distribution of lipid-binding regions in human apolipoprotein B-100G C Chen, D A Hardman, R L Hamilton, et al.
The Journal of Biological Chemistry|November 18, 1994
Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjectsG C Chen, W Liu, P Duchateau, et al.
Obesity Research|August 10, 1999
Absence of cardiac valve dysfunction in obese patients treated with sibutramineD S Bach, A M Rissanen, C M Mendel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young menG Copinschi, A Van Onderbergen, M L'Hermite-Balériaux, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteersY Lee, J A Conroy, M E Stepanavage, et al.
Neuroendocrinology|February 12, 1998
Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in manG Copinschi, R Leproult, A Van Onderbergen, et al.
The Journal of Clinical Investigation|March 1, 1995
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinityC R Pullinger, L K Hennessy, J E Chatterton, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|July 25, 2000
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trialF G McMahon, K Fujioka, B N Singh, et al.
Endocrinology|January 1, 1989
Uptake of cortisol by the perfused rat liver: validity of the free hormone hypothesis applied to cortisolC M Mendel, R W Kuhn, R A Weisiger, et al.
JAMA|February 7, 1986
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathyC M Mendel, R F Klein, D A Chappell, et al.
Biochemistry|March 21, 1989
Distribution of lipid-binding regions in human apolipoprotein B-100G C Chen, D A Hardman, R L Hamilton, et al.
The Journal of Biological Chemistry|November 18, 1994
Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjectsG C Chen, W Liu, P Duchateau, et al.
Obesity Research|August 10, 1999
Absence of cardiac valve dysfunction in obese patients treated with sibutramineD S Bach, A M Rissanen, C M Mendel, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young menG Copinschi, A Van Onderbergen, M L'Hermite-Balériaux, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteersY Lee, J A Conroy, M E Stepanavage, et al.
Neuroendocrinology|February 12, 1998
Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in manG Copinschi, R Leproult, A Van Onderbergen, et al.
The Journal of Clinical Investigation|March 1, 1995
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinityC R Pullinger, L K Hennessy, J E Chatterton, et al.
Pageof 6